Data collection protocol for specialist harm reduction agencies
EMCDDA / Correlation Project, 56 p.
This booklet has been complied within Correlation – European Network Social Inclusion & Health. The project aims to improve access to and the improvement of health and social services for marginalised groups and people. Data collection and evaluation are considered as an important measure to improve the knowledge and evidence base in particular for low threshold services.
The booklet describes the development and the field testing of a data collection protocol for harm reduction agencies and presents the final tool, including a manual. You can find additional information and the inventory on www.correlation-net.org.
Working Group :
- Randi Ervik, Diakonhjemmet University College, Oslo, Norway
- Jean Long, Health Research Board, Dublin, Ireland
- Xavier Majo Roca, Department of Health Catalonia
- Ferenc Marvanykövi, RIDS Budapest, Hungary
- Jozsef Racz, RIDS Budapest, Hungary
- Abdalla Toufik, OFDT Paris, France.
- Dagmar Hedrich, EMCDDA, Lisbon, Portugal
Download the pdf file (282 Ko)
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2018 EMCDDA European Drug Report.
Country drug reports 2017
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.